Clinical Trial Update: Amifostine in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating amifostine for treating myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED